Benzofuran-substituted urea derivatives as novel P2Y1 receptor antagonists

被引：29

作者：

Thalji, Reema K. ^{[1
]}

Aiyar, Nambi ^{[2
]}

Davenport, Elizabeth A. ^{[3
]}

Erhardt, Joseph A. ^{[4
]}

Kallal, Lorena A. ^{[3
]}

Morrow, Dwight M. ^{[5
]}

Senadhi, Shobha ^{[2
]}

Burns-Kurtis, Cynthia L. ^{[2
]}

Marino, Joseph P., Jr. ^{[6
]}

机构：

[1] GlaxoSmithKline Inc, Dept Chem, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA 19426 USA

[2] GlaxoSmithKline Inc, Dept Biol, Metab Pathways Ctr Excellence Drug Discovery, King Of Prussia, PA 19406 USA

[3] GlaxoSmithKline Inc, Dept Biol Reagents & Assay Dev, Collegeville, PA 19426 USA

[4] GlaxoSmithKline Inc, Canc Res, Collegeville, PA 19426 USA

[5] GlaxoSmithKline Inc, Stem Cell Discovery Performance Unit, Collegeville, PA 19426 USA

[6] GlaxoSmithKline Inc, Metab Pathways Ctr Excellence Drug Discovery, Dept Chem, King Of Prussia, PA 19406 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 14期

关键词：

P2Y(1); Purinergic; Thrombosis; Antiplatelet; Urea; P2; RECEPTORS; AGONISTS; ATP;

D O I：

10.1016/j.bmcl.2010.05.072

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Benzofuran-substituted urea analogs have been identified as novel P2Y(1) receptor antagonists. Structure activity relationship studies around the urea and the benzofuran moieties resulted in compounds having improved potency. Several analogs were shown to inhibit ADP-mediated platelet activation. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：4104 / 4107

页数：4

共 26 条

[1] Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriersof the Thr-87 variant of the ATP receptor P2Y11 [J].

Amisten, Stefan ;

Melander, Olle ;

Wihlborg, Anna-Karin ;

Berglund, Goran ;

Erlinge, David .

EUROPEAN HEART JOURNAL, 2007, 28 (01) :13-18

[2] 2-chloro N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate is a selective high affinity P2Y1 receptor antagonist [J].

Boyer, JL ;

Adams, M ;

Ravi, RG ;

Jacobson, KA ;

Harden, TK .

BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (08) :2004-2010

[3] Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors [J].

Camaioni, E ;

Boyer, JL ;

Mohanram, A ;

Harden, TK ;

Jacobson, KA .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :183-190

[4] Iodination of thallium(I) salts of phenols [J].

Cambie, RC ;

Larsen, DS ;

Rutledge, PS ;

Woodgate, PD .

AUSTRALIAN JOURNAL OF CHEMISTRY, 1997, 50 (07) :767-769

[5]

Chao H.J., 2005, Urea antagonists of p2y1receptor useful in the treatment of thrombotic conditions, Patent No. [2005113511, WO/2005/113511]

[6] Prasugrel A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention [J].

Duggan, Sean T. ;

Keating, Gillian M. .

DRUGS, 2009, 69 (12) :1707-1726

[7] Regulation of platelet functions by P2 receptors [J].

Gachet, C .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :277-300

[8] The P2 receptors in platelet function [J].

Hechler, B ;

Cattaneo, M ;

Gachet, C .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (02) :150-161

[9]

Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113

[10]

Herpin T. F., 2005, [No title captured], Patent No. [WO 2005070920, 2005070920]

← 1 2 3 →